In fact, cognitive decline or co-pathology of tau and amyloid beta accumulation at advanced disease stages are likely to add (primary or secondary) to the development of anxiety symptoms or vice versa anxiety appears to predict the risk to develop mild cognitive deficits82–84. Here, MAPT is linked to Anxiety.